Email
Password
Remember meForgot password?
    Log in with Twitter

study halted by NIH News

Eli Lilly's antibody drug for COVID-19 patients fails in study

Late on Monday, the National Institute of Allergy and Infectious Diseases (NIAID), ended a study into the effectiveness of Eli Lilly's antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness.
 

Search Digital Journal Archives


Set up a news alert for

study halted by NIH


study halted by NIH Image


Latest News
Top News